Review of supplements with limited or no evidence

The Case of HMB and its Ineffectiveness in Advanced Athletes

Hydroxymethylbutyrate, popularly marketed as HMB, is presented on the market as a potent shield against fiber degradation and a formidable catalyst for hypertrophic development.

Although its theoretical basis suggests an involvement in membrane repair, severe clinical audits have dismantled its purported goodness in the athletic population.

While isolated trials indicated slight initial gains, long-term controlled investigations performed on subjects with prior powerlifting experience revealed no significant alterations in maximal strength, no increases in lean body composition, and no measurable mitigation of tissue damage versus ingestion of a simple placebo.

Consequently, the authorities relegate it to categories of null sports recommendation.

Nitric Oxide Precursors (L-Arginine) and Marketing

Supplements focused on stimulating the production of nitric oxide, whose central axis is the amino acid L-Arginine, dominate the bodybuilding sector under the premise of generating extreme vasodilation.

The advertising theory argues that increased arterial widening will flood the tissue with oxygen, promoting superior mechanical congestion.

However, rigorous clinical evidence supporting a tangible increase in human myofibrillar synthesis from this mechanism is notably lacking and scarce.

To worsen this empirical vacuum, the industry often masks these products by adding colossal doses of caffeine and potent nerve excitants, the latter being the real culprits responsible for the sensation of alertness, not the theoretical vasodilation.

Collagen and exogenous ketones: Promises and empirical gaps

In the field of joint recovery and lipid metabolism, supplements such as collagen peptides and exogenous ketones emerge, supported by monumental marketing machines.

In the case of collagenous structures, specialists agree that the science supporting their direct articular assimilation is extremely fragile, lacking the evidential firmness that even conventional gelatines of mass consumption have.

In parallel, ketogenic supplements, designed to induce an artificially altered metabolic state, are mired in fierce academic debate.

To date, they lack the unanimous backing of governing bodies, relegating them to an experimental limbo far removed from the proven effectiveness r